Comparison of the hypoalgesic efficacy of low-frequency and burst-modulated kilohertz frequency currents.

BACKGROUND AND PURPOSE: A within-subject randomized controlled trial was conducted to compare monophasic pulsed current (PC) with a frequency of 50 Hz and a phase duration of 500 microseconds with burst-modulated alternating current (BMAC) (1-kHz alternating current, burst modulated at a frequency o...

Descripción completa

Detalles Bibliográficos
Publicado en:Physical Therapy Vol. 87; no. 8; pp. 1056 - 1064
Autores principales: Ward AR, Oliver WG
Formato: clinical trial research tables/charts Journal Article
Publicado: Oxford University Press / USA Aug2007
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:BACKGROUND AND PURPOSE: A within-subject randomized controlled trial was conducted to compare monophasic pulsed current (PC) with a frequency of 50 Hz and a phase duration of 500 microseconds with burst-modulated alternating current (BMAC) (1-kHz alternating current, burst modulated at a frequency of 50 Hz with a 20% duty cycle) to establish whether there were differences in hypoalgesic efficacy as assessed by cold pain threshold measurements. SUBJECTS: Twenty-two young adults who were healthy and drawn from a population of students of La Trobe University volunteered to participate in the study. Nineteen subjects (7 male, 12 female) met the inclusion criteria. Method: Each participant experienced monophasic PC and BMAC. Time to cold pain threshold was measured before, during, and after the electrical stimulation intervention. RESULTS: Both PC and BMAC currents were effective at elevating the cold pain threshold, although there was no statistically significant difference between the 2 currents during stimulation. DISCUSSION AND CONCLUSION: Pulsed current and BMAC appear to be equally effective at elevating the cold pain threshold. Analysis indicated that if any real difference exists, it would only be apparent with large (100) subject numbers. Any differences in hypoalgesic efficacy thus are not likely to be clinically important.